These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15612375)

  • 21. Distinctive skeletal phenotype in high bone mass osteogenesis imperfecta due to a COL1A2 cleavage site mutation.
    Nishimura G; Nakajima M; Takikawa K; Haga N; Ikegawa S
    Am J Med Genet A; 2016 Aug; 170(8):2212-4. PubMed ID: 27264419
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical localization of interstitial collagens in bone tissue from patients with various forms of osteogenesis imperfecta.
    Nerlich AG; Brenner RE; Wiest I; Lehmann H; Yang C; Müller PK; von der Mark K
    Am J Med Genet; 1993 Jan; 45(2):258-9. PubMed ID: 8456813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy with pamidronate in children with osteogenesis imperfecta.
    Marginean O; Tamasanu RC; Mang N; Mozos I; Brad GF
    Drug Des Devel Ther; 2017; 11():2507-2515. PubMed ID: 28894358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation on assistive technologies for the seating and mobility needs of persons with osteogenesis imperfecta.
    Axelson P; Zollars JA
    Connect Tissue Res; 1995; 31(4):S45-7. PubMed ID: 15612381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What every clinical geneticist should know about testing for osteogenesis imperfecta in suspected child abuse cases.
    Pepin MG; Byers PH
    Am J Med Genet C Semin Med Genet; 2015 Dec; 169(4):307-13. PubMed ID: 26566591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterising and treating osteogenesis imperfecta.
    Bishop N
    Early Hum Dev; 2010 Nov; 86(11):743-6. PubMed ID: 20846798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
    Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Osteogenesis imperfecta: therapeutic difficulties--apropos of 17 cases].
    Zouari O; Gargouri A; Fakhfakh B; Sliman N
    Tunis Med; 1995 May; 73(5):179-82. PubMed ID: 9507280
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pathologic anatomy of osteogenesis imperfecta. Light and electron microscopic studies of supportive tissue and skin].
    Stöss H
    Veroff Pathol; 1990; 134():1-88. PubMed ID: 2385955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Intrinsic Muscle Weakness on Muscle-Bone Crosstalk in Osteogenesis Imperfecta.
    Gremminger VL; Phillips CL
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.
    Trejo P; Rauch F
    Osteoporos Int; 2016 Dec; 27(12):3427-3437. PubMed ID: 27492436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteogenesis imperfecta: diagnosis and treatment.
    Palomo T; Vilaça T; Lazaretti-Castro M
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):381-388. PubMed ID: 28863000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteogenesis imperfecta: rehabilitation approach with infants and young children.
    Binder H; Hawks L; Graybill G; Gerber NL; Weintrob JC
    Arch Phys Med Rehabil; 1984 Sep; 65(9):537-41. PubMed ID: 6477088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etiology of osteogenesis imperfecta: an overview of biochemical and molecular genetic analyses.
    Byers PH
    Connect Tissue Res; 1995; 31(4):257-9. PubMed ID: 15612363
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda.
    Baron R; Gertner JM; Lang R; Vignery A
    Pediatr Res; 1983 Mar; 17(3):204-7. PubMed ID: 6835724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hip Dysplasia in Children With Osteogenesis Imperfecta: Association With Collagen Type I C-Propeptide Mutations.
    Kishta W; Abduljabbar FH; Gdalevitch M; Rauch F; Hamdy R; Fassier F
    J Pediatr Orthop; 2017; 37(7):479-483. PubMed ID: 26371943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1.
    Ben Amor IM; Roughley P; Glorieux FH; Rauch F
    J Bone Miner Res; 2013 Sep; 28(9):2001-7. PubMed ID: 23529829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up.
    Engelbert RH; Uiterwaal CS; Gerver WJ; van der Net JJ; Pruijs HE; Helders PJ
    Arch Phys Med Rehabil; 2004 May; 85(5):772-8. PubMed ID: 15129402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.